Home

IRESSA - 250mg - 30

ATC	B/G	Ingredients	code	Registration Nb	Name	Dosage	Presentation	Form	Route	Agent	Laboratory	Country	Price	Pharmacist Margin	Stratum	Responsible Party Name	Responsible Party Country	Exch_date	%SUBSIDY
L01EB01	B	Gefitinib - 250mg	6238	218930/10	IRESSA	250mg	30	Tablet, fim coated	Oral	Omnipharma	NIPRO Pharma Corporation, Kagamiishi Plant	Japan	135,027,509 L.L	2.44	E2	AstraZeneca UK Ltd	UK	12/12/20	0

ATC	B/G	Ingredients	code	Registration Nb	Name	Dosage	Presentation	Form	Route	Agent	Laboratory	Country	Price	Pharmacist Margin	Stratum	Responsible Party Name	Responsible Party Country	Exch_date	%SUBSIDY
L01EB01	G	Gefitinib - 250mg	10135	161719/1	GEFITINIB BIOGARAN	250mg	30	Tablet, coated	Oral	Commercial and Trading Ressources SAL (CTR)	Remedica Ltd	Cyprus	79,286,959 L.L	2.44	E2	Laboratoires Biogaran	France	12/12/20	0
L01EB01	G	Gefitinib - 250mg	10728	152119/1	GEFITINIB ARROW	250mg	30	Tablet, coated	Oral	Darapharma S.A.L.	Remedica Ltd	Cyprus	77,701,762 L.L	2.44	E2	Arrow Génériques	France	12/12/20	0
L01EB01	G	Gefitinib - 250mg	10823	95720/1	APO-GEFITINIB	250mg	30	Tablet	Oral	Promopharm S.A.R.L.	Apotex Inc	Canada	87,345,820 L.L	2.44	E2	Apotex Inc	Canada	12/12/20	0
L01EB01	G	Gefitinib - 250mg	10135/388	161719/1	GEFITINIB BIOGARAN	250mg	30	Tablet, coated	Oral	Commercial and Trading Ressources SAL (CTR)	Remedica Ltd	Cyprus	L.L	2.44	E2	Laboratoires Biogaran	France	05/02/20
L01EB01	G	Gefitinib - 250mg	10728/388	152119/1	GEFITINIB ARROW	250mg	30	Tablet, coated	Oral	Darapharma S.A.L.	Remedica Ltd	Cyprus	L.L	2.44	E2	Arrow Génériques	France	05/02/20